Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era
Neuro-Oncology: The Podcast - A podcast by Neuro-Oncology - Fridays
Dr. Iyad Alnahhas interviews Dr. Max Kros about his and his team's recent manuscript entitled: "Mitotic count is prognostic in IDH-mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trials 26053 and EORTC 22033-26033", published online in Neuro-Oncology in December 2022. Read Paper
